Donald A. Kalkofen

Chief Financial Officer, Protagonist Therapeutics, Inc.

Companies

Genvor IncChief financial officer May 26, 2026 to now¹
Protagonist Therapeutics, IncChief financial officer Jun 3, 2019 to Feb 17, 2022²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Protagonist Therapeutics, Inc PTGX18,521 shares³$2.5M at $134.03Feb 15, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 15, 2022Granted 7,500 shares of Protagonist Therapeutics, Inc³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARGenvor Inc, Chief financial officer
2
SEC EDGARProtagonist Therapeutics, Inc, Chief financial officer
3
SEC EDGARProtagonist Therapeutics, Inc shares after the filing of Feb 15, 2022